Introduction：Basic information about CAS 100403-19-8|Ceramides Mixture, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Ceramides Mixture |
|---|
| CAS Number | 100403-19-8 | Molecular Weight | 397.63488 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C24H47NO3 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | Ceramides |
|---|
| Synonym | More Synonyms |
|---|
Ceramides Mixture BiologicalActivity
| Description | Ceramides Mixture is an endogenous ceramide and consists of hydroxy and non-hydroxy fatty acid-containing ceramides. Ceramides Mixture is a main lipid component of the permeability barrier in epidermis. Ceramides Mixture is involved in the regulation of growth inhibition, cell cycle arrest, and modulation of telomerase activity[1][2]. |
|---|
| Related Catalog | Research Areas >>EndocrinologySignaling Pathways >>Cell Cycle/DNA Damage >>TelomeraseResearch Areas >>Metabolic Disease |
|---|
| In Vitro | Endogenous Ceramides (generated in response to bacterial sphingomyelinase overexpression or daunorubicin treatment) inhibits mRNA synthesis of telomerase reverse transcriptase and telomerase activity via inactivation of c-Myc transcription factor in the A549 human lung adenocarcinoma cell line[1]. The sustained generation of long chain endogenous ceramide requires the biochemical recycling of the sphingosine backbone of C6-ceramide, which involves deacylation and reacylation of ceramide for the generation of endogenous long chain ceramide (mainly C16:0- and C24:1-Ceramides), most likely by CoA-dependent ceramide synthase, which is inhibited by fumonisin B1. In A549 cells the generation of long chain endogenous ceramide mediates the effects of exogenous C6-ceramide on growth inhibition, cell cycle arrest, and the modulation of telomerase activity[1]. |
|---|
| References | [1]. Ogretmen B, et al. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J Biol Chem. 2002 Apr 12;277(15):12960-9. [2]. Macheleidt O, et al. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol. 2002 Jul;119(1):166-73. |
|---|
Chemical & Physical Properties
| Molecular Formula | C24H47NO3 |
|---|
| Molecular Weight | 397.63488 |
|---|
| InChIKey | ATGQXSBKTQANOH-ISLYRVAYSA-N |
|---|
| SMILES | CCCCCCCCC=CCCCCCCCC(=O)NC(CO)C(O)C(O)CCCCCCCCCCCCCC |
|---|
| Storage condition | -20°C |
|---|
Safety Information
Synonyms
| ceramide 1 |
| ceramide 1 a |
| caproyl sphingosine |
| EINECS 309-560-3 |
| ceramide 5 |
| ceramide 6 ii |
| ceramide 4 |
| ceramide 3 |
| ceramide 2 |
